Main Pharmacological Strategies Against SARS-CoV-2
There are currently no specific drugs for COVID-19. However, several drugs approved for other situations, as well as several investigative agents, are being studied for the treatment of COVID-19 in several hundred clinical trials worldwide. In anticipation of the results of clinical trials, differen...
Saved in:
| Main Authors: | Thais Gonçalves Fontes, Afrânio Côgo Destefani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bucharest College of Physicians
2020-09-01
|
| Series: | Modern Medicine |
| Subjects: | |
| Online Access: | https://medicinamoderna.ro/wp-content/uploads/2020/09/RMM_art-3.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
by: Abdullah G. Al-Sehemi, et al.
Published: (2022-05-01) -
Vaccination against the SARS-CoV-2 in individuals with comorbidities
by: S A Berns, et al.
Published: (2025-02-01) -
Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV
by: Vahid Rajabali Zadeh, et al.
Published: (2025-05-01) -
SARS-CoV-2 and Coronaviruses: Understanding Transmission, Impact, and Strategies for Prevention and Treatment
by: Seyede Nafise Tabatabaei, et al.
Published: (2025-02-01) -
Aptamer-engaged nanotherapeutics against SARS-CoV-2
by: Jing Zhang, et al.
Published: (2025-04-01)